- Home
- QNT vs PBH Comparison
QNT vs PBH Comparison
Compare QNT & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNT | PBH |
|---|---|---|
| Founded | 2021 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2026 | 2004 |
Fundamental Metrics
Financial Performance| Metric | QNT | PBH |
|---|---|---|
| Price | $46.83 | $45.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $97.17 | $67.80 |
| AVG Volume (30 Days) | ★ 1.5M | 451.4K |
| Earning Date | 11-17-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | N/A | $17.03 |
| Revenue Next Year | $102.03 | $6.06 |
| P/E Ratio | ★ N/A | $76.54 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $46.54 | $42.62 |
| 52 Week High | $86.79 | $71.07 |
Technical Indicators
Market Signals| Indicator | QNT | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 42.53 | 39.28 |
| Support Level | $46.94 | $44.73 |
| Resistance Level | $53.25 | $49.79 |
| Average True Range (ATR) | 2.84 | 1.30 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 15.27 | 32.07 |
Price Performance
Historical ComparisonAbout QNT Quantinuum Inc. Class A Common Stock
Quantinuum Inc. is providing a full-stack quantum technology solution to scale quantum computing and develop applications. Its products and solutions are Quantinuum Systems, Helios, Quantum Origin, InQuanto, Nexus, and Developer Tools.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.